Denali Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 11/12/2025 | 12.29 M | $178.45 M | 1.96% | 7.17% |
| VANGUARD GROUP INC | 11/07/2025 | 11.99 M | $174.14 M | 1.54% | 7.00% |
| BAILLIE GIFFORD & CO | 10/31/2025 | 11.59 M | $168.31 M | -3.04% | 6.76% |
| FMR LLC | 11/13/2025 | 6.34 M | $92.06 M | -15.89% | 3.70% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2025 | 5.64 M | $81.87 M | 73.66% | 3.29% |
| UBS ASSET MANAGEMENT AMERICAS INC | 11/14/2025 | 5.47 M | $79.35 M | -12.73% | 3.19% |
| STATE STREET CORP | 11/14/2025 | 5.46 M | $79.34 M | 20.94% | 3.19% |
| TEMASEK HOLDINGS (PRIVATE) LTD | 11/14/2025 | 5.36 M | $77.77 M | 0.00% | 3.12% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 11/13/2025 | 4.76 M | $69.13 M | 0.22% | 2.78% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 4.57 M | $66.33 M | -30.60% | 2.66% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 3.73 M | $54.18 M | 0.00% | 2.18% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 3.52 M | $51.12 M | 12.22% | 2.05% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 3.47 M | $50.34 M | 9.26% | 2.02% |
| CRESTLINE MANAGEMENT, LP | 11/14/2025 | 3.41 M | $49.52 M | -11.66% | 1.99% |
| HOLOCENE ADVISORS, LP | 11/14/2025 | 3.14 M | $45.53 M | 677.76% | 1.83% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 2.52 M | $36.58 M | 13.80% | 1.47% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 2.36 M | $34.23 M | -2.31% | 1.37% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 2.16 M | $31.42 M | 16.00% | 1.26% |
| UBS GROUP AG | 11/13/2025 | 2.01 M | $29.22 M | 111.66% | 1.17% |
| STEMPOINT CAPITAL LP | 11/14/2025 | 1.73 M | $25.19 M | 145.04% | 1.01% |
| MORGAN STANLEY | 11/14/2025 | 1.69 M | $24.53 M | 28.77% | 0.99% |
| FISHER ASSET MANAGEMENT, LLC | 11/12/2025 | 1.63 M | $23.69 M | 7.62% | 0.95% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.31 M | $18.98 M | 45.16% | 0.76% |
| PRINCIPAL FINANCIAL GROUP INC | 11/04/2025 | 1.27 M | $18.46 M | 18.47% | 0.74% |
| NORTHERN TRUST CORP | 11/14/2025 | 1.23 M | $17.92 M | 2.70% | 0.72% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 1.15 M | $16.72 M | 9.03% | 0.67% |
| ABRDN PLC | 11/07/2025 | 1.11 M | $16.17 M | 23.35% | 0.65% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 11/14/2025 | 1.00 M | $14.52 M | 100.00% | 0.58% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 961.14 K | $13.96 M | 47.82% | 0.56% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 936.23 K | $13.59 M | 21.51% | 0.55% |
| CASDIN CAPITAL, LLC | 11/14/2025 | 890.00 K | $12.92 M | 0.00% | 0.52% |
| CANDRIAM S.C.A. | 11/06/2025 | 833.58 K | $12.10 M | -1.26% | 0.49% |
| SIREN, L.L.C. | 11/13/2025 | 821.51 K | $11.93 M | 0.00% | 0.48% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 800.75 K | $11.63 M | 1.26% | 0.47% |
| MARSHALL WACE, LLP | 11/13/2025 | 787.03 K | $11.43 M | -43.99% | 0.46% |
| MASTERS CAPITAL MANAGEMENT LLC | 11/14/2025 | 750.00 K | $10.89 M | 25.00% | 0.44% |
| CITADEL ADVISORS LLC | 11/14/2025 | 688.22 K | $9.99 M | -44.90% | 0.40% |
| CERCANO MANAGEMENT LLC | 11/07/2025 | 625.00 K | $9.08 M | 0.00% | 0.36% |
| ENSIGN PEAK ADVISORS, INC | 11/13/2025 | 534.07 K | $7.75 M | 12.75% | 0.31% |
| SEGALL BRYANT & HAMILL, LLC | 11/12/2025 | 512.96 K | $7.45 M | 2.48% | 0.30% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 499.16 K | $7.25 M | 20.25% | 0.29% |
| YIHENG CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 469.98 K | $6.82 M | 0.00% | 0.27% |
| BARCLAYS PLC | 11/12/2025 | 437.00 K | $6.35 M | 2.59% | 0.25% |
| TREXQUANT INVESTMENT LP | 11/14/2025 | 430.57 K | $6.25 M | 294.14% | 0.25% |
| PALO ALTO INVESTORS LP | 11/14/2025 | 408.01 K | $5.92 M | 70.14% | 0.24% |
| TD ASSET MANAGEMENT INC | 11/10/2025 | 394.60 K | $5.73 M | -20.49% | 0.23% |
| ROYAL BANK OF CANADA | 11/14/2025 | 372.18 K | $5.40 M | -4.61% | 0.22% |
| CLARIUS GROUP, LLC | 10/14/2025 | 359.75 K | $5.22 M | -2.51% | 0.21% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 357.34 K | $5.19 M | 12.30% | 0.21% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2025 | 305.00 K | $4.43 M | 5.17% | 0.18% |
Denali Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 311 institutional investors and hedge funds held shares of Denali Therapeutics Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 12.29 M
VANGUARD GROUP INC: 11.99 M
BAILLIE GIFFORD & CO: 11.59 M
FMR LLC: 6.34 M
T. Rowe Price Investment Management, Inc.: 5.64 M
UBS ASSET MANAGEMENT AMERICAS INC: 5.47 M
79.04% of Denali Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 158.19 M shares in the last 24 months. This purchase volume represents approximately $3.16 B in transactions.